NeurologyWire

Botox Approved for Lower Limb Spasticity

From NeurologyWire

The FDA has approved Botox (onabotulinumtoxinA) for the treatment of lower limb spasticity in adult patients to decrease the severity of increased muscle stiffness in ankle and toe muscles. The approval was based on a large, international development program that included a phase three, multi-center, double-blind, randomized, placebo-controlled cli...

Login to read story

Thursday, February 04, 2016

Show last days of articles

FDA Psychopharmacologic Advisory Committee Endorses Brintell...

From NeurologyWire

The FDAs Psychopharmacologic Drugs Advisory Committee (PDAC) voted 8 to 2 that Takeda Pharmaceutical Company Limited and H. Lundbeck presented substan...Full story

Friday, January 29, 2016

Research Consortium Identifies Key Piece in Parkinson's Dise...

From NeurologyWire

An international public-private research consortium has identified and validated a cellular role of a primary Parkinson's disease drug target: the LRR...Full story

FDA Approves ZembraceSymTouch Drug-Device Combination Inject...

From NeurologyWire

The FDA has approved ZembraceSymTouch (sumatriptan succinate, Dr. Reddy Laboratories) injection, a drug-device combination product intended for the tr...Full story

Onzetra Xsail Nasal Powder Approved for Treatment of Migrain...

From NeurologyWire

The FDA has approved Onzetra Xsail (sumatriptan nasal powder, Avanir Pharmaceuticals), formerly known as AVP-825, for the acute treatment of migraine ...Full story

Thursday, January 28, 2016

FDA Approves Extended-Release Orally Disintegrating Amphetam...

From NeurologyWire

The FDA has approved Adzenys XR-ODT (Neos Therapeutics), an extended-release orally disintegrating tablet for the treatment of attention-deficity/hype...Full story

Wednesday, January 27, 2016

Lilly and Roche Diagnostics Partnering on Alzheimer's Diseas...

From NeurologyWire

Eli Lilly and Company and Roche Diagnostics are partnering on the ongoing development of a commercially scalable cerebrospinal fluid assay for amyloid...Full story

Tuesday, January 26, 2016

Synthetic Nerve Capping Device Cleared by FDA

From NeurologyWire

The FDA granted 510(k) clearance for Neurocap, a device designed to reduce painful neuroma formation and facilitate tissue repair and regeneration. It...Full story

Friday, January 22, 2016

Botox Approved for Lower Limb Spasticity

From NeurologyWire

The FDA has approved Botox (onabotulinumtoxinA) for the treatment of lower limb spasticity in adult patients to decrease the severity of increased mus...Full story

Tuesday, January 19, 2016

EMD Serono Takes Over Sole US Rights to Rebif

From NeurologyWire

EMD Serono has taken over the sole US rights to Rebif (interferon beta-1a) for the treatment of relapsing forms of multiple sclerosis (MS) to decrease...Full story

RF Ablation Device for Painful Spine Metastases Receives FDA...

From NeurologyWire

The FDA has granted 510(k) clearance to Medtronic for its OsteoCool RF Ablation System for use in patients with painful spine metastases. The OsteoCoo...Full story

Thursday, January 14, 2016

High Levels of Urate in Blood Associated with Lower Risk of ...

From NeurologyWire

Men who have high levels of urate in their blood may be less likely to develop Parkinsons disease, according to a study published in Neurology (Januar...Full story

Monday, January 11, 2016

Blocking Inflammation Shown to Slow Alzheimers Development

From NeurologyWire

Blocking inflammation in the brain may slow the progression of Alzheimers disease (AD), according to a new study published in Brain (January 6). To un...Full story

Thursday, January 07, 2016

Estriol Combined with Glatiramer Acetate Found Effective for...

From NeurologyWire

Estriol plus glatiramer acetate may reduce relapse rates in women with relapsing-remitting multiple sclerosis (MS), new findings indicate. Noting that...Full story

Wednesday, January 06, 2016

FDA Grants Breakthrough Status to Niemann-Pick Type C1 Disea...

From NeurologyWire

The FDA has granted Breakthrough Therapy designation status to a drug candidate for the treatment of Niemann-Pick Type C1 Disease (NPC), Breakthrough ...Full story

Tuesday, January 05, 2016

Xeomin Approved for Upper Limb Spasticity in Adults

From NeurologyWire

The FDA has approved Xeomin (incobotulinumtoxinA, Merz North America) for the treatment of upper limb spasticity (ULS) in adult patients. In clinical ...Full story